Lartruvo

Pronunciation

A drug used with doxorubicin to treat soft tissue sarcoma that cannot be treated with radiation therapy or surgery. It is used in patients whose cancer has not already been treated with an anthracycline (a type of anticancer drug). It is also being studied in the treatment of other types of cancer. Lartruvo binds to a receptor for a protein called platelet-derived growth factor (PDGF), which is found on some types of cancer cells. Blocking this protein receptor may help keep cancer cells from growing and prevent the growth of new blood vessels that tumors need to grow. Lartruvo is a type of monoclonal antibody. Also called anti-PDGFR alpha monoclonal antibody IMC-3G3, anti-platelet-derived growth factor receptor alpha monoclonal antibody IMC-3G3, IMC-3G3, and olaratumab. (NCI Dictionary)

YOU MAY ALSO LIKE

Larson Regimen

A regimen consisting of five phases used for the treatment of adult lymphoblastic leukemia. The five phases include: induction, early intensification, central…

Larotaxel

A semi-synthetic derivative of the taxane 10-deacetylbaccatin III with potential antineoplastic activities. Larotaxel binds to tubulin, promoting microtubule assembly and stabilization and…

Laropiprant

A prostaglandin D2 receptor (DP1) antagonist with niacin-induced vasodilation inhibiting activity. Laropiprant binds to and inhibits the activity of DP1, a G-protein…

Laromustine

A drug used to treat acute myelogenous leukemia (AML). It is also being studied in the treatment of several other types of…

Largetrifoliolious Bugbane Rhizome Supplement

A proprietary tablet formulation containing an extract from Largetrifoliolious Bugbane rhizome (Shengma), the dried root of Cimicifuga sp., with potential use for…

Largest

Greatest in size of those under consideration.